Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers
Bristol-Myers Squibb Company's dividend payout ratio (DPR) is now 58.87%. A number of other institutional investors have also recently bought and sold shares of the business. Among 6 analysts coveri...